WB
Western blot analysis of GABARAPL1-Specific using anti-GABARAPL1-Specific antibody. The sample well of each lane was loaded with 30 ug of sample under reducing conditions.
Lane 1: human SiHa whole cell lysates,
Lane 2: human Hela whole cell lysates,
Lane 3: human U251 whole cell lysates,
Lane 4: rat liver tissue lysates,
Lane 5: rat brain tissue lysates,
Lane 6: mouse liver tissue lysates,
Lane 7: mouse brain tissue lysates.
After electrophoresis, proteins were transferred to a membrane. Then the membrane was incubated with rabbit anti-GABARAPL1-Specific antigen affinity purified polyclonal antibody at a dilution of 1:1000 and probed with a goat anti-rabbit IgG-HRP secondary antibody. The signal is developed using ECL Plus Western Blotting Substrate. A specific band was detected for GABARAPL1-Specific at approximately 19 kDa. The expected band size for GABARAPL1-Specific is at 14 kDa.
IHC
IHC analysis of GABARAPL1-Specific using anti-GABARAPL1-Specific antibody.
GABARAPL1-Specific was detected in a paraffin-embedded section of human liver cancer tissue. The tissue section was incubated with rabbit anti-GABARAPL1-Specific Antibody at a dilution of 1:200 and developed using HRP Conjugated Rabbit IgG Super Vision Assay Kit with DAB as the chromogen.